• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/43

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

43 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)
moa of macrolides
Inhibits protein synthesis by binding -reversibly to 50 S ribosomal subunit
-Interfere with binding of other antibiotics – clindamycin and chloramphenicol
macrolides are statis or cidal
static,
cidal vs c. jejni
t/f macrolides cover gram +: strep and staph but has no clinical evidence vs staph and is only tested in the club
true,
erythromycin covers
gram +
-strep
-staph (not really)

gram -:
-campylobacter jejuni
-moraxella catarrhalis
-bordetella pertussis
-n. gonorrhea

other
-atypicals + hb
Legionella pneumophilia
Mycoplasma pneumoniae
Chalamydia pneumoniae
Chlamydia trachomatis
Treponema pallidum
H. pylori
Borrelia burgdorferi
clarithyromycin covers
gram +
-strep
-staph (not really)

gram -:
gram -:
-campylobacter jejuni
-moraxella catarrhalis
-bordetella pertussis
-n. gonorrhea
-hemophilus influenza

other
-atypicals + hb+ mt
Legionella pneumophilia
Mycoplasma pneumoniae
Chalamydia pneumoniae
Chlamydia trachomatis
H. pylori
Borrelia burgdorferi
Mycobacteria spp.
Toxoplasma gondii
Mycobacteria spp.
how does gram - coverage differ b/t ery and clarith
- clarithyro covers ery gram - + hemophillus influenza
how does clarithy other coverage comp to erythy
- ery box (- treponema pallidum)
- + mycobacteria spp. , toxoplasma gondii
azith spectrum of coverage
gram +
-strep
-staph (not really)

gram -:
-campylobacter jejuni
-moraxella catarrhalis
-bordetella pertussis
-n. gonorrhea
-hemophilus influenza
-ecoli
-salmonella
-shigella
(clarith box + hess)

other
-atypicals + hb+ mt
Legionella pneumophilia
Mycoplasma pneumoniae
Chalamydia pneumoniae
Chlamydia trachomatis
H. pylori
Borrelia burgdorferi
Mycobacteria spp.
Toxoplasma gondii
Mycobacteria spp.
-treponema pallidum
which abx covers treponema pallidum: ery, clarith, azith
covers: ery and azith
not: clarith
macrolides cover gram + bacillus?
no
Macrolides are the doc for staph aures?
no, not 1st or 2nd line
macrolides are the doc for staph epi
no
remember staph coverage only dx tool
macrolides cover saprophyticus?
- no
macrolides cover strep pneumonia?
- yes
ery absorption
- Erratic, inactivated by gastric
acid (EC formulations)
- better with salt form than base:
(estolate>ethylsuccinate>stearat
e)
- F = low
clarith absorption
Rapid absorption
- Acid stable
azith absorption
- rapid absorption
- acid stable
- f dec by food ( newly formulated tabs, may be taken w/out regard to food)
macrolide distribution
distributes widely, except CSF
 intracellular (phagocytes & macrophages)/tissue concentration >> plasma
concentration
(azithromycin [tissue] 10 -100 X > [plasma])
macrolide distribution in the blood?
- very little goes into the blood
- dnt give in bug is in the blood
ery,clar and azith are eliminated by?
hepatic and renal
ery, clarith, azith
half life
ery: 1.6 hrs
clar: 5-7 hrs
azith: 68 hrs
clarith elimination needs dosage adj?
yes, crcl <30 ml/min
- avoid use in severe hepatic impairment
ery dosage frequency ?
q 6 hrs
clarith admin: biaxin xl w/ or w/out food
with food
clarith dosage frequency
po q 24 hrs
ery adr
- gi
-cholestatic hepatitis
- otoxtoxicity
-phlebitis
clarith adr
- n/d/abd cramps
- metallic taste
- inc liver enzymes
azith adr
- n/d/adb cramps
- inc liver enzymes
pregnancy categories
ery, clarith, azith
- preg B: ery, azith
- preg C: clarith
drug interactions of ery,clarith,azith
-Inhibition of CYP450 1A2 & 3A4
o Theophylline, cyclosporine, carbamazepine, warfarin, astemizole ...etc. (potential
interaction with other substrates of these enzymes)

- Inhibition of gut flora responsible for digoxin digestion (documented with E, caution with
C & A)

-Increased digoxin level

-Competitive binding to 50 S ribosomal subunit
o Antagonizes effects of clindamycin and chloramphenicol
clarith covers community aquired pneumonia
yes
telithromycin moa
-Inhibits protein synthesis by binding to 23S ribosomal RNA of 50S ribosomal subunit
- 23S has 5 domains (I-V)
- Clarithromycin and telithromycin binds to II and V
telithromycin is static or cidal
static
telithromycin spectrum of activity
gram +
-staph aures
-streptococcus: pneu, pyogenes

gram -
haemophilus influ
moraxella catarrhalis

inactive vs
-enterobacteriaceae
-psa aeruginosa

other (atypicals)
-chlamydophilia pneumoniae
-legionella pneumophila
-mycoplasma pneumoniae

anaerobes
-clostridium
-peptostreptococcus
-proprionibacterium
-provetella
gram -: hm
other: clm

anaerobes 3p + c
clinical indications for telithyromycin, explain the change
Before February 2007
-Community-acquired pneumonia (CAP)
- Acute exacerbation of chronic
bronchitis (AECB)
- Acute bacterial sinusitis (ABS)

After feb 12, 2007
Community-acquired pneumonia (CAP)
absorption of telithy
- 90% absorption
metabolism of telith
- cyp 3a4 inhibitor
adr of telithromycin
- myasthenia gravis
- hepatotoxicity
- visual disturbances
- gi
- cardiac: qtc prolongation
-
contraindications of telithromycin
- hepatotoxicity
bbw of telithromycin
- myasthenia gravis
telithromycin pregnancy category
preg cat c
inc telithromycin levels
- itraconazole
-ketoconazole
dec telithromycin levels
-CRaPP

-carbamezapine
-rifampin
-phenobarbital
-phenytoin